业界动态国内医卫资讯
达格列净可能减少肝硬化患者的腹水
Medscape News · 2026-11-13 04:57
摘要
达格列净可能改善肝硬化及难治性腹水患者的腹水控制,并减少对腹腔穿刺和白蛋白使用的需求。Medscape Medical News
English
Dapagliflozin May Reduce Ascites in Patients With Cirrhosis
Dapagliflozin may improve ascites control in patients with cirrhosis and refractory ascites and reduce the need for paracentesis and albumin use. Medscape Medical News